Login / Signup

Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy.

Giovanni ApoloneEmanuele MontomoliAlessandro ManentiMattia BoeriFederica SabiaInesa HyseniLivia MazziniDonata MartinuzziLaura CantoneGianluca MilaneseStefano SestiniPaola SuatoniAlfonso MarchianòValentina BollatiGabriella SozziUgo Pastorino
Published in: Tumori (2020)
There are no robust data on the real onset of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and spread in the prepandemic period worldwide. We investigated the presence of SARS-CoV-2 receptor-binding domain (RBD)-specific antibodies in blood samples of 959 asymptomatic individuals enrolled in a prospective lung cancer screening trial between September 2019 and March 2020 to track the date of onset, frequency, and temporal and geographic variations across the Italian regions. SARS-CoV-2 RBD-specific antibodies were detected in 111 of 959 (11.6%) individuals, starting from September 2019 (14%), with a cluster of positive cases (>30%) in the second week of February 2020 and the highest number (53.2%) in Lombardy. This study shows an unexpected very early circulation of SARS-CoV-2 among asymptomatic individuals in Italy several months before the first patient was identified, and clarifies the onset and spread of the coronavirus disease 2019 (COVID-19) pandemic. Finding SARS-CoV-2 antibodies in asymptomatic people before the COVID-19 outbreak in Italy may reshape the history of pandemic.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • coronavirus disease
  • clinical trial
  • electronic health record
  • big data
  • machine learning
  • deep learning
  • quantum dots
  • phase iii
  • phase ii
  • label free